SCHEMBL6326935

SCHEMBL6326935

C=C(CCCC)c1ccc(Cc2c(C)[nH]c3ccc(C(=O)OC)cc23)c(Cl)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
ATM Q13315 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
KDM4E B2RXH2 6/20 0.44
ALDH1A1 P00352 5/20 0.44
HSD17B10 Q99714 4/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
ALOX12 P18054 1/20 0.44
MAPK1 P28482 1/20 0.44
HPGD P15428 4/20 0.43
ALOX15 P16050 1/20 0.43
CASP1 P29466 1/20 0.43
PTPN5 P54829 1/20 0.42
MAPT P10636 4/20 0.41
LMNA P02545 2/20 0.41
HCRTR1 O43613 1/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6318590 0.90 PTPN5 (0.48) MEN1KMT2AL3MBTL1KDM4EALDH1A1
SCHEMBL6319585 0.84 PPARG (0.44) KDM4EPTPN5MAPTLMNAHTT
SCHEMBL5881887 0.83 KDM4E (0.50) MEN1KMT2AATML3MBTL1KDM4E
SCHEMBL6327087 0.82 PTGS2 (0.39) ALDH1A1PTPN5MAPTLMNAGAA
SCHEMBL6319384 0.81 KDM4E (0.48) MEN1KMT2AATML3MBTL1KDM4E
SCHEMBL6320006 0.81 MEN1 (0.45) MEN1KMT2AATML3MBTL1KDM4E
SCHEMBL6322504 0.81 MEN1 (0.45) MEN1KMT2AATML3MBTL1KDM4E
SCHEMBL6325133 0.81 POLB (0.49) MEN1KMT2AATML3MBTL1KDM4E
SCHEMBL5882184 0.80 PDE3B (0.56) MEN1KMT2AATML3MBTL1KDM4E
SCHEMBL5881928 0.79 MEN1 (0.50) MEN1KMT2AATML3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050171185-A1 Indole derivatives FUJISAWA PHARMACEUTICAL CO., LTD., A JAPANESE CORPORATION 2005-08-04 US disclosed
CN-1150167-C Indole derivatives ����ҩƷ��ҵ��ʽ���� 2004-05-19 CN disclosed
CN-1303371-A Indole derivatives FUJISAWA PHARMACEUTICAL CO (JP) 2001-07-11 CN disclosed
EP-1070705-A1 INDOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-01-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171185-A1 Indole derivatives PDE5A, IGFBP5, HTR5A MEN1 3818/4885KMT2A 1146/4885ATM 2938/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.